{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:01:39Z","timestamp":1792681299476,"version":"4.5.0"},"reference-count":70,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Appl Thromb Hemost"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>Cardiomyopathies are commonly believed to have genetic origins; however, the connection between cardiomyopathies and cardiovascular diseases remains uncertain. Thus, we employed a Mendelian randomization (MR) approach to investigate the potential causal effects of specific cardiovascular disease subtypes on dilated and hypertrophic cardiomyopathies, focusing primarily on a European population. Summary-level data for cardiomyopathies and other cardiovascular diseases were obtained from public genome-wide association studies. Random-effects inverse-variance weighting was used as the primary analysis, whereas sensitivity analyses, including weighted median, MR\u2013Egger, and multivariable MR methods, were also conducted. A genetic predisposition to atrial fibrillation [odds ratio (OR): 1.33; 95% confidence interval (CI): 1.18\u20131.50; P\u2009&lt;\u20090.001], heart failure (OR: 3.22; 95% CI: 1.92-5.41; P\u2009&lt;\u20090.001), and hypertension (OR: 1.50; 95% CI: 1.25-1.81; P\u2009&lt;\u20090.001) were causally linked to an increased risk of developing dilated cardiomyopathy. However, there was no direct causal connection between genetically predicted coronary heart disease, pulmonary embolism, or ischemic stroke and the risk of developing dilated cardiomyopathy. In contrast, no significant associations were found between genetically predicted CVD subtypes and the risk of developing hypertrophic cardiomyopathy. Genetically predicted heart failure is significantly associated with the risk of developing dilated cardiomyopathy, underscoring the importance of effective heart failure management for risk prevention. Moreover, individuals with hypertension and atrial fibrillation might have an increased predisposition to dilated cardiomyopathy, highlighting crucial implications for management.<\/jats:p>","DOI":"10.1177\/10760296251328011","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:43:45Z","timestamp":1743201825000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Mendelian Randomization Study on the Associations Between Genetically Predicted Cardiovascular Disease Subtypes and the Risk of Developing Cardiomyopathies"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6722-7311","authenticated-orcid":false,"given":"Qiaolin","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9807-3774","authenticated-orcid":false,"given":"Xiangzhu","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9153-3628","authenticated-orcid":false,"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"issue":"7","key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCRESAHA.117.309711","article-title":"Classification, epidemiology, and global burden of cardiomyopathies","volume":"121","author":"McKenna WJ","year":"2017","unstructured":"McKenna WJ, Maron BJ, Thiene G. Classification, epidemiology, and global burden of cardiomyopathies. Circ Res. 2017;121(7):722\u2013730. doi:https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.309711","journal-title":"Circ Res"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad194"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0428-2"},{"issue":"20","key":"e_1_3_4_5_2","first-page":"1977","article-title":"Clinical course and management of hypertrophic cardiomyopathy","volume":"379","author":"Maron BJ","year":"2018","unstructured":"Maron BJ. Clinical course and management of hypertrophic cardiomyopathy. N Engl J Med. 2018;379(20):1977. doi:https:\/\/doi.org\/10.1056\/NEJMc1812159","journal-title":"N Engl J Med"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00608-2"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.12.002"},{"issue":"1","key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev-med-042220-021539","article-title":"Hypertrophic cardiomyopathy: New concepts and therapies","volume":"73","author":"Maron BJ","year":"2022","unstructured":"Maron BJ, Rowin EJ, Maron MS. Hypertrophic cardiomyopathy: New concepts and therapies. Annu Rev Med. 2022;73(1):363\u2013375. doi:https:\/\/doi.org\/10.1146\/annurev-med-042220-021539","journal-title":"Annu Rev Med"},{"issue":"11","key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/GIM.0b013e3181f2481f","article-title":"Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals","volume":"12","author":"Hershberger RE","year":"2010","unstructured":"Hershberger RE, Morales A, Siegfried JD. Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals. Genet Med. 2010;12(11):655\u2013667. doi:https:\/\/doi.org\/10.1097\/GIM.0b013e3181f2481f","journal-title":"Genet Med"},{"issue":"10406","key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(23)01241-2","article-title":"Dilated cardiomyopathy: Causes, mechanisms, and current and future treatment approaches","volume":"402","author":"Heymans S","year":"2023","unstructured":"Heymans S, Lakdawala NK, Tsch\u00f6pe C, Klingel K. Dilated cardiomyopathy: Causes, mechanisms, and current and future treatment approaches. Lancet. 2023;402(10406):998\u20131011. doi:https:\/\/doi.org\/10.1016\/S0140-6736(23)01241-2","journal-title":"Lancet"},{"issue":"1","key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss HP","year":"2019","unstructured":"Schultheiss HP, Fairweather D, Caforio ALP, et al. Dilated cardiomyopathy. Nat Rev Dis Primers. 2019;5(1):32. Published 2019 May 9. doi:https:\/\/doi.org\/10.1038\/s41572-019-0084-1","journal-title":"Nat Rev Dis Primers"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12944"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309396"},{"issue":"2","key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1103","article-title":"Evolving concepts in dilated cardiomyopathy","volume":"20","author":"Merlo M","year":"2018","unstructured":"Merlo M, Cannat\u00e0 A, Gobbo M, Stolfo D, Elliott PM, Sinagra G. Evolving concepts in dilated cardiomyopathy. Eur J Heart Fail. 2018;20(2):228\u2013239. doi:https:\/\/doi.org\/10.1002\/ejhf.1103","journal-title":"Eur J Heart Fail"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad736"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2022.05.015"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43586-021-00092-5"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw373"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000559"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1201\/b18084"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016010098"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2018.00051"},{"issue":"5","key":"e_1_3_4_23_2","first-page":"693","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases [published correction appears in Nat Genet. 2018 Aug;50(8):1196. https:\/\/doi.org\/10.1038\/s41588-018-0164-2]","volume":"50","author":"Verbanck M","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases [published correction appears in Nat Genet. 2018 Aug;50(8):1196. https:\/\/doi.org\/10.1038\/s41588-018-0164-2]. Nat Genet. 2018;50(5):693\u2013698. doi:https:\/\/doi.org\/10.1038\/s41588-018-0099-7","journal-title":"Nat Genet"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965"},{"issue":"1","key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1038\/s41467-023-43771-5","article-title":"Genome-wide association analysis of left ventricular imaging-derived phenotypes identifies 72 risk loci and yields genetic insights into hypertrophic cardiomyopathy","volume":"14","author":"Ning C","year":"2023","unstructured":"Ning C, Fan L, Jin M, et al. Genome-wide association analysis of left ventricular imaging-derived phenotypes identifies 72 risk loci and yields genetic insights into hypertrophic cardiomyopathy. Nat Commun. 2023;14(1):7900. doi:https:\/\/doi.org\/10.1038\/s41467-023-43771-5","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1038\/s41467-022-34216-6","article-title":"Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure","volume":"13","author":"Levin MG","year":"2022","unstructured":"Levin MG, Tsao NL, Singhal P, et al. Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure. Nat Commun. 2022;13(1):6914. doi:https:\/\/doi.org\/10.1038\/s41467-022-34216-6","journal-title":"Nat Commun"},{"issue":"7952","key":"e_1_3_4_27_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-023-05837-8","article-title":"Author Correction: FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"615","author":"Kurki MI","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, et al. Author Correction: FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;615(7952):E19. doi:https:\/\/doi.org\/10.1038\/s41586-023-05837-8","journal-title":"Nature"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00954-4"},{"issue":"7938","key":"e_1_3_4_29_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-022-05492-5","article-title":"Stroke genetics informs drug discovery and risk prediction across ancestries","volume":"612","author":"Mishra A","year":"2022","unstructured":"Mishra A, Malik R, Hachiya T, et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature. 2022;612(7938):E7. doi:https:\/\/doi.org\/10.1038\/s41586-022-05492-5","journal-title":"Nature"},{"issue":"1","key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-ecolsys-120213-091721","article-title":"Constraints evolve: Context dependency of gene effects allows evolution of pleiotropy","volume":"46","author":"Pavli\u010dev M","year":"2015","unstructured":"Pavli\u010dev M, Cheverud JM. Constraints evolve: Context dependency of gene effects allows evolution of pleiotropy. Annu Rev Ecol Evol Syst. 2015;46(1):413\u2013434. doi:https:\/\/doi.org\/10.1146\/annurev-ecolsys-120213-091721","journal-title":"Annu Rev Ecol Evol Syst."},{"issue":"1","key":"e_1_3_4_31_2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a040501","article-title":"Mendelian randomization: Concepts and scope","volume":"12","author":"Richmond RC","year":"2022","unstructured":"Richmond RC, Smith GD. Mendelian randomization: Concepts and scope. Cold Spring Harbor Perspect Med. 2022;12(1):a040501. doi:https:\/\/doi.org\/10.1101\/CSHPERSPECT.A040501","journal-title":"Cold Spring Harbor Perspect Med."},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr036"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.15555.1"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6522"},{"issue":"06","key":"e_1_3_4_36_2","article-title":"Use of Mendelian randomisation to assess potential benefit of clinical intervention","volume":"345","author":"Burgess S","year":"2012","unstructured":"Burgess S, Butterworth A, Malarstig A, Thompson SG. Use of Mendelian randomisation to assess potential benefit of clinical intervention. Br Med J. 2012;345(nov06 1):e7325. Published 2012 Nov 6. doi:https:\/\/doi.org\/10.1136\/bmj.e7325","journal-title":"Br Med J."},{"issue":"2","key":"e_1_3_4_37_2","article-title":"Evaluating the potential role of pleiotropy in Mendelian randomization studies","volume":"27","author":"Hemani G","year":"2018","unstructured":"Hemani G, Bowden J, Davey Smith G. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27(R2):R195\u2013R208. doi:https:\/\/doi.org\/10.1093\/hmg\/ddy163","journal-title":"Hum Mol Genet"},{"issue":"2","key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s40484-020-0216-3","article-title":"Mendelian randomization and pleiotropy analysis","volume":"9","author":"Zhu X","year":"2021","unstructured":"Zhu X. Mendelian randomization and pleiotropy analysis. Quant Biol. 2021;9(2):122\u2013132. doi:https:\/\/doi.org\/10.1007\/s40484-020-0216-3","journal-title":"Quant Biol"},{"issue":"2","key":"e_1_3_4_39_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/gepi.22512","article-title":"Weak and pleiotropy robust sex-stratified Mendelian randomization in the one sample and two sample settings","volume":"47","author":"Karageorgiou V","year":"2023","unstructured":"Karageorgiou V, Tyrrell J, Mckinley TJ, Bowden J. Weak and pleiotropy robust sex-stratified Mendelian randomization in the one sample and two sample settings. Genet Epidemiol. 2023;47(2):135\u2013151. doi:https:\/\/doi.org\/10.1002\/gepi.22512","journal-title":"Genet Epidemiol"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2012.09.002"},{"issue":"3","key":"e_1_3_4_41_2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1586\/erm.10.13","article-title":"Evolving molecular diagnostics for familial cardiomyopathies: At the heart of it all","volume":"10","author":"Callis TE","year":"2010","unstructured":"Callis TE, Jensen BC, Weck KE, Willis MS. Evolving molecular diagnostics for familial cardiomyopathies: At the heart of it all. Expert Rev Mol Diagn. 2010;10(3):329\u2013351. doi:https:\/\/doi.org\/10.1586\/erm.10.13","journal-title":"Expert Rev Mol Diagn"},{"issue":"8","key":"e_1_3_4_42_2","first-page":"1190","article-title":"Epidemiology of cardiomyopathies: Essential context knowledge for a tailored clinical work-up","volume":"29","author":"Pasqualucci D","year":"2022","unstructured":"Pasqualucci D, Iacovoni A, Palmieri V, et al. Epidemiology of cardiomyopathies: Essential context knowledge for a tailored clinical work-up. Eur J Prev Cardiol. 2022;29(8):1190\u20131199. doi:https:\/\/doi.org\/10.1093\/eurjpc\/zwaa035","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"e_1_3_4_43_2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/eurheartj\/ehr260","article-title":"Genetics of inherited cardiomyopathy","volume":"33","author":"Jacoby D","year":"2012","unstructured":"Jacoby D, McKenna WJ. Genetics of inherited cardiomyopathy. Eur Heart J. 2012;33(3):296\u2013304. doi:https:\/\/doi.org\/10.1093\/eurheartj\/ehr260","journal-title":"Eur Heart J"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI62862"},{"issue":"25","key":"e_1_3_4_45_2","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1016\/j.jacc.2016.08.079","article-title":"Clinical and mechanistic insights into the genetics of cardiomyopathy","volume":"68","author":"Burke MA","year":"2016","unstructured":"Burke MA, Cook SA, Seidman JG, Seidman CE. Clinical and mechanistic insights into the genetics of cardiomyopathy. J Am Coll Cardiol. 2016;68(25):2871\u20132886. doi:https:\/\/doi.org\/10.1016\/j.jacc.2016.08.079","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_4_46_2","doi-asserted-by":"crossref","first-page":"796926","DOI":"10.1155\/2012\/796926","article-title":"Cardiomyopathy classification: Ongoing debate in the genomics era","volume":"2012","author":"McCartan C","year":"2012","unstructured":"McCartan C, Mason R, Jayasinghe SR, Griffiths LR. Cardiomyopathy classification: Ongoing debate in the genomics era. Biochem Res Int. 2012;2012:796926. doi:https:\/\/doi.org\/10.1155\/2012\/796926","journal-title":"Biochem Res Int"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccep.2018.11.001"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c140055"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-020-09940-0"},{"issue":"25","key":"e_1_3_4_50_2","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","article-title":"The diagnosis and evaluation of dilated cardiomyopathy","volume":"67","author":"Japp AG","year":"2016","unstructured":"Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol. 2016;67(25):2996\u20133010. doi:https:\/\/doi.org\/10.1016\/j.jacc.2016.03.0590","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"e_1_3_4_51_2","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.123.004301","article-title":"Imagenetics for precision medicine in dilated cardiomyopathy","volume":"17","author":"Antonopoulos AS","year":"2024","unstructured":"Antonopoulos AS, Xintarakou A, Protonotarios A, et al. Imagenetics for precision medicine in dilated cardiomyopathy. Circ Genom Precis Med. 2024;17(2):e004301. doi:https:\/\/doi.org\/10.1161\/CIRCGEN.123.004301","journal-title":"Circ Genom Precis Med"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1715"},{"issue":"2","key":"e_1_3_4_53_2","article-title":"Hypertrophic cardiomyopathy: Genetics and clinical perspectives","volume":"9","author":"Wolf CM","year":"2019","unstructured":"Wolf CM. Hypertrophic cardiomyopathy: Genetics and clinical perspectives. Cardiovasc Diagn Ther. 2019;9(Suppl 2):S388\u2013S415. doi:https:\/\/doi.org\/10.21037\/cdt.2019.02.01","journal-title":"Cardiovasc Diagn Ther"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.02.010"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1461"},{"issue":"6","key":"e_1_3_4_56_2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/CIRCRESAHA.113.300282","article-title":"Genetic cardiomyopathies causing heart failure","volume":"113","author":"Cahill TJ","year":"2013","unstructured":"Cahill TJ, Ashrafian H, Watkins H. Genetic cardiomyopathies causing heart failure. Circ Res. 2013;113(6):660\u2013675. doi:https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.300282","journal-title":"Circ Res"},{"issue":"1","key":"e_1_3_4_57_2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jacc.2012.07.072","article-title":"Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy","volume":"61","author":"Kubanek M","year":"2013","unstructured":"Kubanek M, Sramko M, Maluskova J, et al. Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy. J Am Coll Cardiol. 2013;61(1):54\u201363. doi:https:\/\/doi.org\/10.1016\/j.jacc.2012.07.072","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"e_1_3_4_58_2","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/ejhf.1216","article-title":"Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy","volume":"20","author":"Halliday BP","year":"2018","unstructured":"Halliday BP, Gulati A, Ali A, et al. Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy. Eur J Heart Fail. 2018;20(10):1392\u20131400. doi:https:\/\/doi.org\/10.1002\/ejhf.1216","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"e_1_3_4_59_2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.amjcard.2019.04.028","article-title":"Meta-analysis of atrial fibrillation in patients with Various cardiomyopathies","volume":"124","author":"Noubiap JJ","year":"2019","unstructured":"Noubiap JJ, Bigna JJ, Agbor VN, et al. Meta-analysis of atrial fibrillation in patients with Various cardiomyopathies. Am J Cardiol. 2019;124(2):262\u2013269. doi:https:\/\/doi.org\/10.1016\/j.amjcard.2019.04.028","journal-title":"Am J Cardiol"},{"issue":"23","key":"e_1_3_4_60_2","article-title":"Atrial fibrillation in patients with cardiomyopathy: Prevalence and clinical outcomes from real-world data","volume":"10","author":"Buckley BJR","year":"2021","unstructured":"Buckley BJR, Harrison SL, Gupta D, Fazio-Eynullayeva E, Underhill P, Lip GYH. Atrial fibrillation in patients with cardiomyopathy: Prevalence and clinical outcomes from real-world data. J Am Heart Assoc. 2021;10(23):e021970. doi:https:\/\/doi.org\/10.1161\/JAHA.121.021970","journal-title":"J Am Heart Assoc"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311059"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2017.06.14"},{"issue":"3","key":"e_1_3_4_63_2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.118.11125","article-title":"Myocardial remodeling in hypertension: Toward a new view of hypertensive heart disease","volume":"72","author":"Gonz\u00e1lez A","year":"2018","unstructured":"Gonz\u00e1lez A, Ravassa S, L\u00f3pez B, et al. Myocardial remodeling in hypertension: Toward a new view of hypertensive heart disease. Hypertension. 2018;72(3):549\u2013558. doi:https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.11125","journal-title":"Hypertension"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-016-2431-9"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.537878"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-economics-080218-025643"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40471-017-0128-6"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219"},{"issue":"8","key":"e_1_3_4_69_2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2217\/epi.15.88","article-title":"Mendelian randomization: Applications and limitations in epigenetic studies","volume":"7","author":"Relton CL","year":"2015","unstructured":"Relton CL, Davey Smith G. Mendelian randomization: Applications and limitations in epigenetic studies. Epigenomics. 2015;7(8):1239\u20131243. doi:https:\/\/doi.org\/10.2217\/epi.15.88","journal-title":"Epigenomics"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyh132"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2023.4115"}],"container-title":["Clinical and Applied Thrombosis\/Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10760296251328011","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10760296251328011","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10760296251328011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:05:07Z","timestamp":1777385107000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10760296251328011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":70,"alternative-id":["10.1177\/10760296251328011"],"URL":"https:\/\/doi.org\/10.1177\/10760296251328011","relation":{},"ISSN":["1076-0296","1938-2723"],"issn-type":[{"value":"1076-0296","type":"print"},{"value":"1938-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"article-number":"10760296251328011"}}